Using real-world evidence to complement evidence from randomized controlled trials on oral anticoagulants for stroke prevention

Mark J. R. Smeets and Suzanne C. Cannegieter discuss the use of real world data to complement data generated by clinical trials of systemic anticoagulants.

Saved in:
Bibliographic Details
Published inPLoS medicine Vol. 21; no. 8; p. e1004449
Main Authors Smeets, Mark J R, Cannegieter, Suzanne C
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 29.08.2024
Public Library of Science (PLoS)
Subjects
Administration, Oral
Anticoagulants (Medicine)
Anticoagulants - administration & dosage
Anticoagulants - therapeutic use
Atrial fibrillation
Atrial Fibrillation - complications
Atrial Fibrillation - drug therapy
Clinical trials
Humans
Medicine and Health Sciences
Physical sciences
Prevention
Randomized Controlled Trials as Topic
Research and Analysis Methods
Stroke (Disease)
Stroke - prevention & control
Online AccessGet full text

Cover

More Information
Summary:Mark J. R. Smeets and Suzanne C. Cannegieter discuss the use of real world data to complement data generated by clinical trials of systemic anticoagulants.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
SCC is a member of the PLOS Medicine Editorial Board.
ISSN:1549-1676
1549-1277
1549-1676
DOI:10.1371/journal.pmed.1004449